A Phase II Study of Loncastuximab Tesirine As Consolidation Strategy in Patients with LBCL in PR at Day 30 after CAR T-Cell Therapy
Ajlan Al Zaki, Lei Feng,Jason Westin,Ranjit Nair,Luis Fayad,Grace Watson,Sherry Adkins,Elizabeth J. Shpall,Mario L. Marques-Piubelli,Jared Henderson,Loretta J. Nastoupil,Christopher R. Flowers,Sairah Ahmed,Sattva S. Neelapu,Paolo Strati BLOOD（2023）
AI 理解论文
溯源树
样例
